Clinical characteristics of pregnant women on the use of daily low-dose aspirin in different hypertensive pregnancy disorders: A retrospective comparative study

Al‐Taie, Anmar; Albasry, Zahraa; Mohammed, Nadia H.

doi:10.4103/jpbs.jpbs_183_18

Cited by 3 publications

(3 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Urine protein tests are negative, and some patients may experience epigastric discomfort or platelet abnormalities. Severe gestational hypertension is defined as systolic blood pressure ≥ 160 mmHg and/or diastolic blood pressure ≥ 110 mmHg [ 18 , 19 ].…”

Section: Experiments and Analysis Of Adjuvant Therapy With Vitamin E ...mentioning

confidence: 99%

See 1 more Smart Citation

The Risk and Clinical Treatment of Hypertensive Diseases in Pregnant Women

Yu²,

Wang³

2022

BioMed Research International

View full text Add to dashboard Cite

Hypertensive disorders of pregnancy are a group of pregnancy-related diseases characterized by the coexistence of pregnancy and elevated blood pressure, which seriously endanger the health of mothers and infants, and are one of the main causes of maternal and perinatal deaths. The purpose of this paper is to investigate the clinical analysis of vitamin E and astragalus in the adjuvant treatment of hypertensive disorders in pregnancy and to describe the learning model. This paper puts forward the problem of clinical treatment, which is established on the basis of adjuvant therapy, then narrates around the clinical characteristics of gestational hypertension, and designs and analyzes the experimental design and analysis of adjuvant therapy with vitamin E and astragalus. The experimental results showed that the delivery methods of the three groups of patients were compared P < 0.05 . Compared with the traditional Chinese medicine control group and the vitamin E control group, there were more vaginal births in the experimental group, 36 patients in total. It shows that astragalus and vitamin E can alleviate the disease in different aspects and can effectively intervene in gestational hypertension.

show abstract

Section: Experiments and Analysis Of Adjuvant Therapy With Vitamin E ...mentioning

confidence: 99%

“…Therapy with Vitamin E and Astragalus Severe gestational hypertension is defined as systolic blood pressure ≥ 160 mmHg and/or diastolic blood pressure ≥ 110 mmHg [18,19].…”

Section: Experiments and Analysis Of Adjuvantmentioning

confidence: 99%

The Risk and Clinical Treatment of Hypertensive Diseases in Pregnant Women

Yu²,

Wang³

2022

BioMed Research International

View full text Add to dashboard Cite

show abstract

“…In the study findings of Ayala et al ,[ 18 ] the BP readings were stable until the 22 nd week of pregnancy and then showed a significant linear BP increase in the second half of pregnancy; such complications could be protected from a single daily use of low-dose aspirin. [ 19 ]…”

Section: Discussionmentioning

confidence: 99%

Potential confounders and a modified Framingham risk score for the prediction of pregnancy-related medical conditions occurrence among pregnant women: A retrospective study from Baghdad, Iraq

2020

Self Cite

View full text Add to dashboard Cite

A BSTRACT Background: The incidence of pregnancy-related medical conditions relied on a set of potential factors that could be available even before the term of pregnancy and may be associated with poor outcomes later in life. This study aimed to investigate the association between some potential predictive factors related to maternal, gestational, and clinical parameters and the incidence of pregnancy-related medical conditions in a sample of Iraqi pregnant women. Materials and Methods: A retrospective, observational, single-center study was carried out on 92 pregnant women during their routine visit to the obstetric clinic in a certain distinct of Baghdad province, Iraq. Demographic, gestational, and clinical records of the participants were collected and analyzed to detect the predictive factors for pregnancy-related medical conditions. Results: 56.5% of the participants were at a gestational age of 25–37 weeks. 32.6% complained of pregnancy-related medical conditions, mainly gestational hypertension and diabetes mellitus. Pregnant women with pregnancy-related medical conditions were significantly correlated with a family history ( P < 0.0001), previous gestational medical conditions ( P < 0.001), diastolic blood pressure ( P = 0.0011), different lipid panels ( P = 0.0001), and maternal blood phenotype O ( P = 0.0001). Conclusion: Some predictive factors related to maternal, gestational, and health characteristics are correlated with the incidence of pregnancy-related medical conditions. Interventions to adjust and recognize these confounders are essentials even before pregnancy which could improve maternal health and reduce the overall risk of pregnancy-related medical conditions.

show abstract

Implementing Screening Guidelines for Preeclampsia Prevention in a Birth Center

Giles

2020

Journal of Perinatal &Amp; Neonatal Nursing

View full text Add to dashboard Cite

The aim of the project was to identify women at risk for developing preeclampsia who present for birth center care in order to initiate preventative treatment and retain them within the birth center practice. Birth center patients with preeclampsia disqualify for birth center care requiring hospital transfer. The target population consisted of pregnant women choosing birth center care with certified nurse midwives. Quality improvement method was utilized. Over 5-weeks, patients with 12 to 28 weeks' gestation were screened for preeclampsia risk factors; patients with high risk for preeclampsia initiated low-dose aspirin (LDA). All patients were evaluated for preeclampsia diagnosis up to 2 weeks postpartum. Outcomes were evaluated through chart audits. Screening for preeclampsia risk significantly increased LDA use. Preeclampsia screening did not statistically reduce incidences of preeclampsia but did show a moderate reduction. Use of LDA did not statistically reduce preeclampsia diagnoses but had a large reduction effect. Screening for preeclampsia in birth center patients results in increased use of LDA and potentially decreased rates of hospital transfer. Implementing preeclampsia screening is cost-effective and allows for increased patient retention.

show abstract

Clinical characteristics of pregnant women on the use of daily low-dose aspirin in different hypertensive pregnancy disorders: A retrospective comparative study

Cited by 3 publications

References 26 publications

The Risk and Clinical Treatment of Hypertensive Diseases in Pregnant Women

The Risk and Clinical Treatment of Hypertensive Diseases in Pregnant Women

Potential confounders and a modified Framingham risk score for the prediction of pregnancy-related medical conditions occurrence among pregnant women: A retrospective study from Baghdad, Iraq

Implementing Screening Guidelines for Preeclampsia Prevention in a Birth Center

Contact Info

Product

Resources

About